NASDAQ · ESTA
Healthcare · Medical - Devices
$75.22
Down-$1.41 (-1.83%)
Updated Aug 19, 2026, 3:46 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
ESTA closed at $75.22 after 21 trading sessions, down 21.36% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $76.42 | $77.48 | $75.02 | $75.215 | 325.51K |
| Aug 17, 2026 | $78.89 | $79.24 | $75.72 | $76.62 | 414.18K |
| Aug 14, 2026 | $76.33 | $81.33 | $75.795 | $79.47 | 496.99K |
| Aug 13, 2026 | $77.53 | $79.59 | $75.39 | $75.59 | 563.37K |
| Aug 12, 2026 | $75.11 | $76.83 | $74.70 | $75.58 | 564.53K |
| Aug 11, 2026 | $76.19 | $76.9799 | $73.825 | $74.28 | 457.16K |
| Aug 10, 2026 | $76.66 | $78.22 | $74.16 | $75.06 | 804.82K |
| Aug 7, 2026 | $78.82 | $80.3999 | $75.69 | $77.42 | 763.65K |
| Aug 6, 2026 | $89.29 | $94.00 | $78.50 | $79.05 | 1.15M |
| Aug 5, 2026 | $93.57 | $96.62 | $90.87 | $91.25 | 912.79K |
| Aug 4, 2026 | $94.09 | $95.28 | $93.34 | $94.61 | 506.27K |
| Aug 3, 2026 | $94.76 | $97.59 | $92.72 | $92.80 | 850.21K |
| Jul 31, 2026 | $93.52 | $94.36 | $91.18 | $92.54 | 323.66K |
| Jul 30, 2026 | $93.72 | $94.395 | $92.67 | $93.48 | 454.78K |
| Jul 29, 2026 | $91.10 | $94.26 | $89.38 | $91.93 | 479.21K |
| Jul 28, 2026 | $92.31 | $94.895 | $90.51 | $91.90 | 393.03K |
| Jul 27, 2026 | $93.70 | $94.68 | $90.95 | $92.10 | 377.21K |
| Jul 24, 2026 | $92.30 | $94.05 | $90.71 | $92.32 | 208.07K |
| Jul 23, 2026 | $92.72 | $94.57 | $91.04 | $91.10 | 549.02K |
| Jul 22, 2026 | $95.35 | $95.80 | $93.27 | $93.87 | 300.78K |
| Jul 21, 2026 | $93.50 | $96.989 | $92.30 | $95.65 | 636.99K |
The latest Smart Investors Daily articles mentioning ESTA.
ESTA research
Company profile and research snapshot.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2026 | Citigroup | Buy | — |
| Aug 7, 2026 | JP Morgan | Overweight | — |
| Aug 6, 2026 | Needham | Buy | — |
| Aug 6, 2026 | BTIG | Buy | — |
| Aug 3, 2026 | TD Cowen | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 13, 2026
Citigroup analyst Joanne Wuensch upgrades Establishment Labs Hldgs (NASDAQ:ESTA) from Neutral to Buy and maintains the price target from $92 to $92.
Benzinga · Aug 7, 2026
JP Morgan analyst Allen Gong maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Overweight and raises the price target from $84 to $95.
SeekingAlpha · Aug 6, 2026
Establishment Labs Holdings Inc. (ESTA) Q2 2026 Earnings Call August 6, 2026 8:30 AM EDTCompany ParticipantsMalavika William - VP, Global Head of Marketing...
Benzinga · Aug 6, 2026
Needham analyst Mike Matson maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from $86 to $95.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ESTA.
